Closed · DARPA-BAA-16-35 · CFDA 12.910 · Discretionary

INTERfering and Co-Evolving Prevention and Therapy

Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.

Varies
Award range
Closed
Status
July 7, 2016
Close date
-
Expected awards

The verdict

INTERfering and Co-Evolving Prevention and Therapy is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 73 other opportunities from DARPA - Biological Technologies Office.

Varies
award range
Closed
application status
12.910
CFDA program
73
other opportunities from DARPA - Biological Technologies Office

Archived opportunity record

INTERfering and Co-Evolving Prevention and Th… is closed (last close July 7, 2016). Check the agency catalog for replacement NOFOs. DARPA - Biological Technologies Office still indexes 73 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed July 7, 2016

Posted Apr 28 Closes Jul 7

Instrument

Procurement Contract

Description

Under the INTERCEPT BAA-16-35, DARPA is soliciting innovative proposals for research to explore and develop therapeutic interfering particles as a novel approach to address infections from fast evolving viral pathogens.

Catch-all / unrestricted eligibility mark · DARPA-BAA-16-35

Grants.gov marks INTERfering and Co-Evolving Prevention and Th… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Biological Technologies Office book (27 peers, 36% of 74).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

James Gimlett, Ph.D. Program Manager Biological Technologies Office (BTO)

More from DARPA - Biological Technologies Office

What to do next

INTERfering and Co-Evolving Prevention and Th… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants